News

Public · Published

Rosenblatt maintains Buy rating on Broadcom, $600 price target

Rosenblatt maintained a Buy rating on Broadcom stock with a $600.00 price target. That target implies an 82.3% upside from the October 26 close of $329.17. The analyst note cited demand exceeding supply and a $63 billion financing transaction supporting Anthropic's compute deployments.

Published:

Updated:

What happened

Rosenblatt maintained a Buy rating on Broadcom stock with a $600.00 price target. That target implies an 82.3% upside from the October 26 close of $329.17. The analyst note cited demand exceeding supply and a $63 billion financing transaction supporting Anthropic's compute deployments.

Confirmed

Global impact / market context

Analyst ratings and price targets can influence how investors view a stock, but a target is an estimate, not a promise. The $600 target suggests the analyst expects Broadcom's revenue and pricing power to hold up, which may shape investor expectations.

Analyst inference

Broadcom operates in the semiconductor market, where strong demand against limited supply can support pricing and revenue. The article describes a company using its balance sheet, meaning its own financial resources, to help fund customer chip purchases tied to AI deployments.

Analyst inference

What to watch

  1. The analyst note said customer forecasts are expected to improve, allowing Broadcom to maintain pricing power despite rising costs across various components. Watch whether these forecasts and costs develop as described. Confirmed
  2. Track the $63 billion financing transaction supporting Anthropic's compute deployments. The article presents it as a way for Broadcom to fund chip sales while earning a return and reducing AI deployment risks. Proposed
  3. Watch whether demand continues to exceed supply for Broadcom's chips, since that balance is central to the analyst's revenue growth view. A shift toward oversupply could weaken the pricing power the note highlights. Analyst inference

Evidence

  • Original source link unavailable